The DOI matches its Crossref record; 472 of the 472 references it cites were found in a registry or an index.
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Open accessAbstract
The dopaminergic system plays important roles in neuromodulation, such as motor control, motivation, reward, cognitive function, maternal, and reproductive behaviors. Dopamine is a neurotransmitter, synthesized in both central nervous system and the periphery, that exerts its actions upon binding to G protein-coupled receptors. Dopamine receptors are widely expressed in the body and function in both the peripheral and the central nervous systems. Dopaminergic signaling pathways are crucial to the maintenance of physiological processes and an unbalanced activity may lead to dysfunctions that are related to neurodegenerative diseases. Unveiling the neurobiology and the molecular mechanisms that underlie these illnesses may contribute to the development of new therapies that could promote a better quality of life for patients worldwide. In this review, we summarize the aspects of dopamine as a catecholaminergic neurotransmitter and discuss dopamine signaling pathways elicited through dopamine receptor activation in normal brain function. Furthermore, we describe the potential involvement of these signaling pathways in evoking the onset and progression of some diseases in the nervous system, such as Parkinson's, Schizophrenia, Huntington's, Attention Deficit and Hyperactivity Disorder, and Addiction. A brief description of new dopaminergic drugs recently approved and under development treatments for these ailments is also provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An extensive literature implicates shared alterations in the reward circuitry in MDD, neurodegenerative disorders, and obesity261-263.”
From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [263]
In the citing paper
“One of the reasons that hinder the diagnosis and treatment of this disorder is the lack of complete understanding of the underlying molecular pathology [16].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [16]
In the citing paper
“DA plays an essential role in mediating regulation of the cortical system, memory, mood, vascular structure, anticipation of events, motivation, behaviour inhibition, decision-making and problem-solving [16, 81, 82].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [16]
Citations
Cites
(1982) · Trends in Neurosciences · doi:10.1016/0166-2236(82)90076-5 · Cited by 9,150
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Research works printed but not linked: 4
- Dale H (1935) Pharmacology and nerve-endings: Walter Ernest Dixon Memorial Lecture. Proc R Soc Med 28:319–332
- Faraone SV, Sergeant J, Gillberg C, Biederman J (2003) The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104
- Hohman LB (1922) Post-encephalitic behavior disorders in children. Johns Hopkins Hospt Bull 33:372–375
- Stryker S (1925) Encephalitis lethargica—the behavior residuals. Train Sch Bull (Vinel) 22:152–157
Cited by
Sorted by citations
Items 601–700 of 999
Levodopa attenuates the feed intake reduction caused by ergot alkaloids in cattle
Valente, É. E. L., Klotz, J. L., Markmann, R. C., Trotta, R. J., Edwards, J. L., May, J. B., & Harmon, D. L. (2024) · Journal of Animal Science · doi:10.1093/jas/skae078 · Cited by 4
Liu, W., Heij, J., Liu, S., Liebrand, L. C., Caan, M. W. A., van der Zwaag, W., Veltman, D. J., Lü, L., Aghajani, M., & van Wingen, G. A. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.07.014 · Cited by 4
Rostami, S., Zibaii, M. I., Babakhani-Fard, M.-M., Layeghi, A., Arefnia, F., Esmaeilpour, R., & Latifi, H. (2025) · Journal of Lightwave Technology · doi:10.1109/jlt.2025.3590515 · Cited by 4
Zou, S., Yi, H., Kimbrough, L. J., Yang, D., Chen, D., Wang, Z., & Liu, B. (2025) · Talanta · doi:10.1016/j.talanta.2025.128672 · Cited by 4
Oonuma, K., & Kusakabe, T. G. (2021) · Development · doi:10.1242/dev.198754 · Cited by 4
Cai, J., Huang, M., Wang, Y., Chen, X., & Ji, M. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128269 · Cited by 4
Functional neuroanatomy of the basal ganglia
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00003-2 · Cited by 4
Jamal, M., Ito, A., Miki, T., Suzuki, S., Ohta, K., & Kinoshita, H. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136689 · Cited by 5
Charron, B., Thibault, V., & Masson, J. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04151-y · Cited by 4
The Dopamine Gene Receptors (DRD1-5) Expression Alteration in Psoriasis Patients
Mohamadian, M., Mortazavi, H., Makvand, M., Ahangari, F., & Ahangari, G. (2022) · Recent Advances in Inflammation & Allergy Drug Discovery · doi:10.2174/2772270816666220629112414 · Cited by 4
A region-dependent allele-biased expression of Dopa decarboxylase in mouse brain
Sheng, K.-Y., Nakano, T., & Yamaguchi, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1078927 · Cited by 3
Ren, S., Geng, W., Cui, X., Wu, B., & Zheng, Z. (2023) · ChemistrySelect · doi:10.1002/slct.202203646 · Cited by 4
Positron Emission Tomography (PET) Imaging Biomarkers in Huntington’s Disease
Everix, L., Staelens, S. G., & Bertoglio, D. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_6 · Cited by 4
Elmers, J., Colzato, L. S., Ziemssen, F., Ziemssen, T., & Beste, C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102280 · Cited by 4
Lyu, Z., Xiao, G., Xie, D., Huang, D., Chen, Y., Wu, C., Lai, Y., Song, Z., Huang, L., Ming, H., et al. (2024) · Brain and Behavior · doi:10.1002/brb3.3605 · Cited by 4
Neural Bases of Financial Decision Making: From Spikes to Large-Scale Brain Connectivity
Kraemer, P. M., Weilbächer, R. A., Fontanesi, L., & Gluth, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-45500-2_1 · Cited by 5
Personalized Nutrition to Treat and Prevent Obesity and Diabetes
Panduro, A., Román, S., Milán, R. G., Torres-Reyes, L. A., & González-Aldaco, K. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160608-00272 · Cited by 4
Kazemi, A., & Djafarian, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817935-2.00048-9 · Cited by 4
Blum, K., Baron, D. A., Jalali, R., Modestino, E. J., Steinberg, B., Elman, I., Badgaiyan, R. D., & Gold, M. S. (2020) · Journal of Systems and Integrative Neuroscience · doi:10.15761/jsin.1000240 · Cited by 4
You, B., Shi, G., Zhang, Y., Fu, X., Li, Q., Wang, Y., Huang, G., Fang, Y., & Li, R. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00500.2024 · Cited by 3
Mansour, M. E. M., Alsaadany, K. R., Ahmed, M. S., & Elmetwalli, A. E. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06723-5 · Cited by 3
Saghafi, M., Danesh, E., Ghalandari-Shamami, M., Mousavi, Z., & Haghparast, A. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115572 · Cited by 3
Soleh, A., Saisahas, K., Samoson, K., Promsuwan, K., Saichanapan, J., Wangchuk, S., Somapa, N., Somapa, D., & Limbut, W. (2025) · Materials Today Chemistry · doi:10.1016/j.mtchem.2025.102872 · Cited by 3
de Andrade, P. R. A., Motta, R. C., & Fonseca‐Santos, B. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126173 · Cited by 4
Label-free plasmonic biosensors for neurodegenerative disease diagnosis: Progress and perspectives
Dun, Y., Chang, L., Zhang, S., Wang, Y., He, X., Zhang, G., & Zhou, J. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118488 · Cited by 3
Sun, H., Xie, X., Li, Y., Zhu, W., Hou, Y., Xie, H., Zhou, B., Zhang, J., Wang, Q., Xie, J., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106136 · Cited by 3
Reversible Antagonism of Dopamine D1 Receptor Using a Photoswitchable Remotely Tethered Ligand
Hetzler, B. E., Donthamsetti, P., Wolesensky, R. M., Stanley, C., Isacoff, E. Y., & Trauner, D. H. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00441 · Cited by 3
Reimagining biogenic amine signaling in the brain and beyond
Vinson, D. A., & Maze, I. S. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.11.003 · Cited by 4
Chen, S., Yang, H., Shen, F., Li, A., Wen, S., Gao, S., Bai, Y., Li, K., & Lin, Y. (2025) · Electroanalysis · doi:10.1002/elan.70087 · Cited by 3
The persisting puzzle of OFF time in advanced Parkinson’s disease
LeWitt, P. A. (2026) · Brain · doi:10.1093/brain/awag002 · Cited by 3
Kim, H., Lee, D., Pyatha, S., & Kim, K. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1801968 · Cited by 3
Neurochemical drivers of effort: The roles of dopamine and beyond in physical and cognitive exertion
Periche-Tomas, E., Husain, M., Apps, M. A. J., Little, S. J., & Harmer, C. J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106696 · Cited by 3
Real-time on-body sweat sensing: Electrochemical insights, progress, and prospects
Saikrithika, S., Zahra, L., Theyagarajan, K., & Kim, Y.-J. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.118882 · Cited by 5
Distinctive characteristics of dopamine neuron release mechanisms: Insights into Parkinson’s Disease
Martino, E. D., Maduro, S., Luchicchi, A., Wilhelmus, M. M. M., & Orefice, N. S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119534 · Cited by 3
Wang, Z., Lu, J., Cui, H., Meng, L., Zheng, J., Miao, W., Lin, J., & Wang, X. (2026) · Scientific Reports · doi:10.1038/s41598-026-50165-2 · Cited by 4
Iwamura, Y., Nakayama, T., Matsumoto, A., Ogi, Y., Yamaguchi, M., Kobayashi, A., Matsumoto, K., Katsura, Y., Konoike, N., Nakamura, K., et al. (2022) · Journal of Neurophysiology · doi:10.1152/jn.00147.2022 · Cited by 3
Endocannabinoid System as a New Therapeutic Avenue for the Treatment of Huntington’s Disease
Saramak, K., & Szejko, N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104566 · Cited by 3
Jain, J., Hasan, W., Jat, D., Biswas, P., & Yadav, R. S. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10282 · Cited by 3
Ultrasound-Induced Prenatal Stress: New Possibilities for Modeling Mental Disorders
Abramova, O. V., Morozova, A. Y., Zubkov, E. A., Ushakova, V., Zorkina, Y., Proshin, A. T., Storozheva, Z. I., Gurina, O. I., & Chekhonin, V. P. (2023) · Developmental Neuroscience · doi:10.1159/000534687 · Cited by 3
Huang, J., Zhou, H., Zou, Y., Liu, H., & Chen, Q. (2024) · The Analyst · doi:10.1039/d4an00398e · Cited by 3
Kuo, P., Hsu, M.-T., Chou, J.-C., Lai, C.-H., Nien, Y., Yang, P.-H., Liao, C.-H., Chen, W.-S., & Huang, J.-M. (2024) · IEEE Transactions on Nanotechnology · doi:10.1109/tnano.2024.3435447 · Cited by 3
Epistatic interactions between oxytocin- and dopamine-related genes and trust
Koyama, Y., Nawa, N., Ochi, M., Surkan, P. J., & Fujiwara, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308728 · Cited by 3
Brown, K. A., Stramiello, M., Clark, J. K., & Wagner, J. J. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00353.2024 · Cited by 3
de Ceglia, M., Romano, A., Bonaventura, M. V. M. D., Gavito, A., Botticelli, L., Bonaventura, E. M. D., Friuli, M., Cifani, C., de Fonseca, F. R., & Gaetani, S. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666241107160840 · Cited by 4
Generation and validation of a D1 dopamine receptor Flpo knock-in mouse
Oppman, A. M., Paradee, W. J., Narayanan, N. S., & Kim, Y.-C. (2024) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2024.110345 · Cited by 3
Franco‐García, A., Gómez‐Murcia, V., Milanés, M. V., & Núñez, C. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70081 · Cited by 3
Hakami, M. A. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.05.026 · Cited by 3
Li, M., Ren, K., Cui, C., Shi, Y., Lei, J., Li, T., Yang, J., Peng, X., Yang, X., Yao, Y., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02139-7 · Cited by 5
Thamaraikannan, T., Karthikeyan, P., SASIEEKHUMAR, A. R., Rathinavelu, A., Poovarasan, M., Saravanakumar, R., Srinivasan, P., & Rajavel, R. (2025) · Applied Physics A · doi:10.1007/s00339-025-08705-6 · Cited by 3
Kaur, R., Rana, S., Singh, H., Mona, M., Singh, J., & Kaur, N. (2025) · Journal of The Electrochemical Society · doi:10.1149/1945-7111/adf2e3 · Cited by 3
Interaction Between Oxytocin and Dopamine Signaling: Focus on the Striatum
Guidolin, D., Tortorella, C., Cervetto, C., Marcoli, M., Maura, G., & Agnati, L. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178711 · Cited by 3
Dopamine modulation of aggression
Dai, B., & Lin, D. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06893-w · Cited by 2
Cai, J., Wang, Y., Chen, X., & Ji, M. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14032 · Cited by 3
Parthimos, T. P., Schulpis, K. H., Karousi, A. D., Loukas, Y. L., & Dotsikas, Y. (2022) · Applied Neuropsychology Adult · doi:10.1080/23279095.2022.2043327 · Cited by 3
MUG: A mutation overview of GPCR subfamily A17 receptors
Caniceiro, A. B., Bueschbell, B., Barreto, C. A. V., Preto, A. J., & Moreira, I. S. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.031 · Cited by 3
Valente, É. E. L., Klotz, J. L., Egert-McLean, A. M., Costa, G. W., May, J. B., & Harmon, D. L. (2023) · Frontiers in Animal Science · doi:10.3389/fanim.2023.1127575 · Cited by 3
Dopaminergic Neurons and Parkinson’s Disease: Current Status, Implications and Future Perspectives
Tong, F. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.5744 · Cited by 3
Metabolism of Dietary Substrates by Intestinal Bacteria and Consequences for the Host Intestine
Blachier, F. (2023) · Springer eBooks · doi:10.1007/978-3-031-26322-4_3 · Cited by 4
Untargeted Metabolomic Analyses of Body Fluids to Differentiate TBI DOC and NTBI DOC
Xiao, X., Xu, L., Lu, H., Liu, X., Sun, H., Guo, Z., Sun, J., Qi, F., Niu, X., Wang, A., et al. (2023) · Current Molecular Medicine · doi:10.2174/0115665240249826230928104512 · Cited by 3
Sočan, V., Dolinar, K., & Kržan, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020911 · Cited by 3
Lin, L., Deng, J., Peng, J., Cui, J., Wang, L., Zhang, M., Gao, J., Li, F., Shi, Y., & Lv, M. (2024) · FEBS Journal · doi:10.1111/febs.17118 · Cited by 3
Ye, S.-H., Zhao, Y., Liu, Z., Luo, C.-P., Xiong, J., Zhan, J., Li, Y., Wei, B., Chen, C., & Yang, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1354999 · Cited by 3
Effect of Dl-3-n-Butylphthalide on olfaction in rotenone-induced Parkinson’s rats
Wang, J., Li, H., Wang, C., Li, D., Zhang, Y., Shen, M., Xu, X., & Wu, T. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1367973 · Cited by 3
Huang, R., Xia, L., Li, J., Shui, Q., Deng, J., & Yang, J. (2024) · Liquid Crystals · doi:10.1080/02678292.2024.2352060 · Cited by 3
Gutiérrez-Mondragón, M. A., Vellido, A., & König, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126572 · Cited by 3
Synthesis and Characterization of Mn₂O₃ and Its Electrochemical Properties in Relation to Dopamine
Suresh, S., Celshia, S., Selvamani, M., Suresh, V., & Hussein, M. A. (2024) · Cureus · doi:10.7759/cureus.67890 · Cited by 3
Niaz, A., Arain, M. B., & Soylak, M. (2025) · Electroanalysis · doi:10.1002/elan.12001 · Cited by 3
RETRACTED: Potential Biomarkers of Fatal Hypothermia Revealed by UHPLC-MS Metabolomics in Mice
Cao, X.-Z., Wu, Z., Ma, X., Deng, W.-L., Chen, D.-H., Liu, J.-L., Li, J.-H., Wang, H., Pei, B., Zhao, D., et al. (2025) · Metabolites · doi:10.3390/metabo15020116 · Cited by 3
RetractedPositron Emission Tomography in Autism Spectrum Disorder: Current Status and Future Perspectives
Ryu, J., & Oh, M. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.06.003 · Cited by 5
Naidoo, V., Martínez-Iglesias, O. A., & Cacabelos, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823039-8.00012-5 · Cited by 3
Unilateral hand force control impairments in older women
Lee, H., Park, Y.-M., & Kang, N. (2022) · EXCLI journal · doi:10.17179/excli2022-5362 · Cited by 4
Pilli, D., Zou, A., Dawes, R., Lopez, J. A., Tea, F., Liyanage, G., Lee, F. X. Z., Merheb, V., Houston, S. D., Pillay, A., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1229 · Cited by 3
Dopa decarboxylase is a genetic hub of parental control over offspring behaviorPreprint
Bonthuis, P. J., Steinwand, S., Huang, W.-C., Hörndli, C. S., Emery, J., Kravitz, S. N., Ferris, E., & Gregg, C. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.23.168195 · Cited by 2
Németh, G., & Csehi, R. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1038627 · Cited by 3
Cheng, Q., Cheng, Q., Steijvers, E., Colvin, R. A., & Lee, D. (2024) · eLife · doi:10.7554/elife.100890.1 · Cited by 3
Hippocampal γCaMKII dopaminylation promotes synaptic-to-nuclear signaling and memory formationPreprint
Stewart, A. F., Fulton, S. L., Cuttoli, R. D.-D., Thompson, R. E., Chen, P., Brindley, E., Cetin, B., Farrelly, L. A., Futamura, R., Claypool, S. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.19.613951 · Cited by 3
Linking microscopic and mean-field descriptions of dopaminergic modulation in neural circuitsPreprint
Casagrande, G., Fedaravičius, A. P., Duprat, C., McIntosh, A. R., Sorrentino, P., Petkoski, S., Saudargienė, A., Jirsa, V., & Depannemaecker, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.01.673498 · Cited by 3
Blachier, F. (2023) · Springer eBooks · doi:10.1007/978-3-031-26322-4_5 · Cited by 2
Ma, P., Wang, X., Wen, X., Pu, L., & Ou, Y. (2024) · Toxicology Research · doi:10.1093/toxres/tfae068 · Cited by 2
Optimizing neurotransmitter pathway detection by IR-MALDESI-MSI in mouse brain
Wang, M. F., Ouyang, Y., Segura, T., & Muddiman, D. C. (2024) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-024-05354-1 · Cited by 2
The C886T Mutation in the Th Gene Reduces the Activity of Tyrosine Hydroxylase in the Mouse Brain
Alsalloum, I., Moskaliuk, V. S., Rakhov, I. A., Базовкина, Д. В., & Kulikov, A. V. (2024) · Biochemistry (Moscow) · doi:10.1134/s000629792406004x · Cited by 2
Li, X., Zhang, Y., Hu, Y., Tang, X., Gong, Z., Lu, R., & Li, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-76981-y · Cited by 2
Fujita, T., Aoki, N., Mori, C., Homma, K. J., & Yamaguchi, S. (2025) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2025.1531200 · Cited by 1
Xia, L., Xu, H., Cao, X., Huang, R., Yang, J., & Deng, J. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.113146 · Cited by 2
Khasawneh, R. R., Abu‐El‐Rub, E., Alzu’bi, A., Almazari, R., Alrabie, A., Almahasneh, F. A., Kasasbeh, A., AI-jariri, H. F., & Mustafa, A. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf025 · Cited by 2
Zhang, C., Shui, S.-Z., Liao, S. Q., Kuang, Y.-C., Yin, D.-Z., Gu, Y., Jalil, B., Heinrich, M., Chen, X., Yin, Z., et al. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107093 · Cited by 2
Copper supplementation enhances pigmentation and induces dopamine production in ARPE19
Uehara, H., Shakaib, B., Kumar, S. R., Archer, B. J., & Ambati, B. K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327352 · Cited by 2
Elgendy, E., Zaky, A., Wahby, M. M., Landry, M., & Bassiouny, A. R. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1542264 · Cited by 2
Wei, J., Wang, L., Wang, D., Chen, W., Guo, L., Ren, M., Guo, F., Ruan, S., Hu, H., Zheng, Y., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01135-4 · Cited by 2
Mechtenberg, H. (2025) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-025-01355-4 · Cited by 2
Analysis of clinical trials on drugs targeting dopamine receptors: a scoping review
Rajan, T., & Seifert, R. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04710-x · Cited by 2
Li, S., Zhang, S., Li, H., Yin, N., Yang, R., Zhang, Y., Koziol, M. J., & Faiola, F. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.140149 · Cited by 2
Zarei, H., Radmehr, M., Mohtasham, A., Mehdipour, M., & Hasani, K. (2025) · Poultry Science · doi:10.1016/j.psj.2025.106007 · Cited by 2
Luo, Z., Li, Z.-F., Lin, Z.-Y., Fu, Z.-Q., Han, F.-L., & Li, E.-C. (2025) · Stress Biology · doi:10.1007/s44154-025-00259-0 · Cited by 3
Daneshpour, A., Karbasi, H., & Haghparast, A. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111616 · Cited by 2
Dopaminergic and Opioid Systems Interact to Produce Peripheral Antinociception in Mice
de Queiroz, B. F. G., Barra, W. C. P., Fonseca, F. C. D. S., Irie, A. L., Romero, T. R. L., & Duarte, I. D. G. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin44311 · Cited by 2
Nunzio, M. D., Mignogna, M. L., Bacigaluppi, M., Panina‐Bordignon, P., Ragonese, P., Muzio, L., Summa, V., & Martino, G. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107194 · Cited by 3
Shakerzadeh, E., Yadav, T., Tahmasebi, E., Vetrivelan, V., & Anota, E. C. (2025) · BioNanoScience · doi:10.1007/s12668-025-02264-z · Cited by 2
Fu, S., & Li, Y. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169669 · Cited by 2
Marcotto, G. S., Bitraj, J., Pich, E. M., & Collo, G. (2026) · Neuroscience Applied · doi:10.1016/j.nsa.2026.106988 · Cited by 3
Metadata
- Authors
- Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G.
- Affiliations
- Universidade de São Paulo (BR)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Bittencourt, Jackson C.
- Correa, Ricardo G.
- ORCID
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2018-11-16
- Volume
- 39
- Issue
- 1
- Pages
- 31-59
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- PMC
- PMC11469830
- OpenAlex
- W2901208536
- Cited by
- 1,073
- References
- 472
- Citations by year
- 2026: 141 · 2025: 174 · 2024: 214 · 2023: 199 · 2022: 148 · 2021: 105 · 2020: 64 · 2019: 27
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- dopamine, dopaminergic signaling, dopamine receptors, G protein-coupled receptors, catecholamine neurotransmitters, neuromodulation, neurodegenerative diseases, Parkinson's disease, schizophrenia, Huntington's disease, attention deficit hyperactivity disorder, addiction, dopaminergic therapy, reward and motivation
- MeSH terms
- Animals, Brain, Dopamine, Humans, Models, Biological, Nervous System Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review